UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Impact of "Killer Immunoglobulin-Like Receptor /Ligand" Genotypes on Outcome following Surgery among Patients with Colorectal Cancer: Activating KIRs Are Associated with Long-Term Disease Free Survival

PloS one, 2015-07, Vol.10 (7), p.e0132526-e0132526

2015

Volltextzugriff (PDF)

A model integrating Killer Immunoglobulin-like Receptor (KIR) haplotypes for risk prediction of COVID-19 clinical disease severity

Immunogenetics (New York), 2021-12, Vol.73 (6), p.449-458

2021

Volltextzugriff (PDF)

Single-Center Study of 72 Patients with Severe Combined Immunodeficiency: Clinical and Laboratory Features and Outcomes

Journal of clinical immunology, 2021-10, Vol.41 (7), p.1563-1573

2021

Volltextzugriff (PDF)

A Bottom-Up Proteomic Approach in Bone Marrow Plasma Cells of Newly Diagnosed Multiple Myeloma Patients

Current proteomics, 2021-11, Vol.18 (5), p.730-741

2021

Volltextzugriff (PDF)

Flow Cytometric Aldehyde Dehydrogenase Assay Enables a Fast and Accurate Human Umbilical Cord Blood Hematopoietic Stem Cell Assessment

Turkish journal of haematology, 2017-12, Vol.34 (4), p.314-320

2017

Volltextzugriff (PDF)

Highlighting the Prognostic Importance of Measurable Residual Disease Among Acute Myeloid Leukemia Risk Factors

Turkish journal of haematology, 2021-01, Vol.38 (2), p.111-118

2021

Volltextzugriff (PDF)

Results of the Hematology Laboratory Survey: What has Changed in Eight Years?

Turkish journal of haematology, 2018, Vol.35 (3), p.215-216

2018

Volltextzugriff (PDF)

Role of Killer Immunoglobulin-Like Receptor and Ligand Matching in Donor Selection

Bone Marrow Research, 2012-01, Vol.2012 (2012), p.99-104

2012

Volltextzugriff (PDF)

Utility investigation of automated techniques in hematopoietic progenitor cell count and viability assessment in the Good Manufacturing Practice (GMP) setting

Experimental biomedical research, 2020-10, Vol.3 (4), p.231-238

2020

Volltextzugriff (PDF)

Post-Induction Undetectable Minimal Residual Disease at 10 -5 Sensitivity Level within Marrow and/or Stem Cell Graft Overrides Cytogenetic High Risk

Blood, 2021-11, Vol.138 (Supplement 1), p.2909-2909

2021

Volltextzugriff (PDF)

Role of large unstained cells in predicting successful stem cell collection in autologous stem cell transplantation

Transfusion and apheresis science, 2023-02, Vol.62 (1), p.103517-103517, Article 103517

2023

Volltextzugriff (PDF)

Common human leucocyte antigensassociated with the development of subacute thyroiditis and COVID-19

Human immunology, 2024-07, Vol.85 (4), p.110834, Article 110834

2024

Volltextzugriff (PDF)

Next Generation Sequencing May be Helpful in Designing Novel Combinations Among Heavily Pretreated Myeloma Patients, Refractory to All Available Approved Anti-Myeloma Drugs

Blood, 2019-11, Vol.134 (Supplement_1), p.3197-3197

2019

Volltextzugriff (PDF)

The Shaping of Modern Human Immune Systems by Multiregional Admixture with Archaic Humans

Science (American Association for the Advancement of Science), 2011-10, Vol.334 (6052), p.89-94

2011

Volltextzugriff (PDF)

Significance of inhibitory maternal killer-cell immunoglobulin-like receptor (KIR) and fetal KIR ligand genotype combinations in placenta related obstetric complications

Journal of reproductive immunology, 2021-11, Vol.148, p.103425-103425, Article 103425

2021

Volltextzugriff (PDF)

Donor-recipient killer immunoglobulin like receptor (KIR) genotype matching has a protective effect on chronic graft versus host disease and relapse incidence following HLA-identical sibling hematopoietic stem cell transplantation

Annals of hematology, 2018-06, Vol.97 (6), p.1027-1039

2018

Volltextzugriff (PDF)

P-132 Post-induction undetectable flow minimal residual disease ameliorates the high risk determined by FISH among newly diagnosed multiple myeloma

Clinical lymphoma, myeloma and leukemia, 2023-09, Vol.23, p.S108-S108

2023

Volltextzugriff (PDF)

Flowcytometric evaluation of cell cycle regulators (cyclins and cyclin dependent kinase inhibitors) expressed on bone marrow cells of patients with chronic myelogenous leukemia and multiple myeloma

Turkish journal of haematology, 2012-03, Vol.29 (1), p.17-27

2012

Volltextzugriff (PDF)

Comparative Proteomic Analysis of Bone Marrow Plasma Cells By Using Mass Spectrometry Based Bottom up Proteomic Strategies

Blood, 2015-12, Vol.126 (23), p.5334-5334

2015

Volltextzugriff (PDF)

A Preliminary Analysis of Inherited Immune Checkpoint Control in Multiple Myeloma: Relative Frequency of Inhibitory or Activating Type Killer Immunoglobulin like Receptors and Their Cognate Ligands HLA-C1 and -C2

Blood, 2017-12, Vol.130, p.4977-4977

2017

Volltextzugriff (PDF)

P-099: Novel targets detected by next generation sequencing among triple refractory patients can be clinically targetable

Clinical lymphoma, myeloma and leukemia, 2022-08, Vol.22, p.S89-S90

2022

Volltextzugriff (PDF)

A Novel Hypothesis: Certain KIR/Cognate Ligand Containing Genotypes Differ in Frequency Among Patients With Myeloma and Have an Effect on Age of Disease Onset

Clinical lymphoma, myeloma and leukemia, 2023-05, Vol.23 (5), p.394-400.e1

2023

Volltextzugriff (PDF)

In vivo and in vitro effects of cord blood hematopoietic stem and progenitor cell (HSPC) expansion using valproic acid and/or nicotinamide

Current research in translational medicine, 2024-09, Vol.72 (3), p.103444, Article 103444

2024

Volltextzugriff (PDF)

KIR 2DS4 May Influence Autologous and Cord Blood(CB) Natural Killer (NK)Cell Mediated in Vitro Cytotoxicity Against Freshly Isolated Human Bone Marrow Myeloma Plasma Cells and Cell Lines

Blood, 2018-11, Vol.132 (Supplement 1), p.1920-1920

2018

Volltextzugriff (PDF)

Residual Clonal Plasma Cells Detected By Flow Cytometry at 10-4level within Autologous Stem Cell Grafts Is Associated with Significantly Less Overall Survival

Blood, 2018-11, Vol.132 (Supplement 1), p.3438-3438

2018

Volltextzugriff (PDF)

1 – 25 von 124

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(111)
Mit Volltextzugriff
(105)

Publikationsform

Sprache

Englisch
(122)
Türkisch
(3)

Erscheinungsjahr

n.n

Thema

Science & Technology
(52)
Life Sciences & Biomedicine
(50)
Humans
(41)
Hematology
(28)
Female
(23)
Male
(21)
Middle Aged
(20)
Adult
(17)
Stem Cells
(11)
Biological And Medical Sciences
(10)
Flow Cytometry
(10)
Health Technology Assessment
(9)
Aged
(8)
Medical Sciences
(8)
Transplantation, Homologous
(8)
Adolescent
(7)
Hematopoietic Stem Cell Transplantation
(7)
Oncology
(7)
Treatment Outcome
(7)
Cell Biology
(6)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Impact of "Killer Immunoglobulin-Like Receptor /Ligand" Genotypes on Outcome following Surgery among Patients with Colorectal Cancer: Activating KIRs Are Associated with Long-Term Disease Free Survival

A model integrating Killer Immunoglobulin-like Receptor (KIR) haplotypes for risk prediction of COVID-19 clinical disease severity

Single-Center Study of 72 Patients with Severe Combined Immunodeficiency: Clinical and Laboratory Features and Outcomes

A Bottom-Up Proteomic Approach in Bone Marrow Plasma Cells of Newly Diagnosed Multiple Myeloma Patients

Flow Cytometric Aldehyde Dehydrogenase Assay Enables a Fast and Accurate Human Umbilical Cord Blood Hematopoietic Stem Cell Assessment

Highlighting the Prognostic Importance of Measurable Residual Disease Among Acute Myeloid Leukemia Risk Factors

Results of the Hematology Laboratory Survey: What has Changed in Eight Years?

Role of Killer Immunoglobulin-Like Receptor and Ligand Matching in Donor Selection

Utility investigation of automated techniques in hematopoietic progenitor cell count and viability assessment in the Good Manufacturing Practice (GMP) setting

Post-Induction Undetectable Minimal Residual Disease at 10 -5 Sensitivity Level within Marrow and/or Stem Cell Graft Overrides Cytogenetic High Risk

Role of large unstained cells in predicting successful stem cell collection in autologous stem cell transplantation

Common human leucocyte antigensassociated with the development of subacute thyroiditis and COVID-19

Next Generation Sequencing May be Helpful in Designing Novel Combinations Among Heavily Pretreated Myeloma Patients, Refractory to All Available Approved Anti-Myeloma Drugs

The Shaping of Modern Human Immune Systems by Multiregional Admixture with Archaic Humans

Significance of inhibitory maternal killer-cell immunoglobulin-like receptor (KIR) and fetal KIR ligand genotype combinations in placenta related obstetric complications

Donor-recipient killer immunoglobulin like receptor (KIR) genotype matching has a protective effect on chronic graft versus host disease and relapse incidence following HLA-identical sibling hematopoietic stem cell transplantation

P-132 Post-induction undetectable flow minimal residual disease ameliorates the high risk determined by FISH among newly diagnosed multiple myeloma

Flowcytometric evaluation of cell cycle regulators (cyclins and cyclin dependent kinase inhibitors) expressed on bone marrow cells of patients with chronic myelogenous leukemia and multiple myeloma

Comparative Proteomic Analysis of Bone Marrow Plasma Cells By Using Mass Spectrometry Based Bottom up Proteomic Strategies

A Preliminary Analysis of Inherited Immune Checkpoint Control in Multiple Myeloma: Relative Frequency of Inhibitory or Activating Type Killer Immunoglobulin like Receptors and Their Cognate Ligands HLA-C1 and -C2

P-099: Novel targets detected by next generation sequencing among triple refractory patients can be clinically targetable

A Novel Hypothesis: Certain KIR/Cognate Ligand Containing Genotypes Differ in Frequency Among Patients With Myeloma and Have an Effect on Age of Disease Onset

In vivo and in vitro effects of cord blood hematopoietic stem and progenitor cell (HSPC) expansion using valproic acid and/or nicotinamide

KIR 2DS4 May Influence Autologous and Cord Blood(CB) Natural Killer (NK)Cell Mediated in Vitro Cytotoxicity Against Freshly Isolated Human Bone Marrow Myeloma Plasma Cells and Cell Lines

Residual Clonal Plasma Cells Detected By Flow Cytometry at 10-4level within Autologous Stem Cell Grafts Is Associated with Significantly Less Overall Survival

Suchergebnisse filtern